Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods.

By S. Stefani, D. Chung, J. Lindsay, A. Friedrich, A. Kearns, H. Westh, F. Mackenzie. International Journal of Antimicrobial Agents, 2012

613 citations recorded by the source corpus.

Subfields: Clinical Biochemistry, Infectious Diseases, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/c5f08559e108ebbb126382b936dcf257002d3287

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Clinical Biochemistry

1. Victor J. Torres
2. Francis Alonzo
3. Kunyan Zhang
4. Sahreena S. Lakhundi

In Infectious Diseases

1. Victor J. Torres
2. Francis Alonzo
3. Kunyan Zhang
4. A. Peschel
5. Hermínia de Lencastre
6. Sahreena S. Lakhundi

In Molecular Biology

1. Victor J. Torres
2. Francis Alonzo
3. Kunyan Zhang
4. A. Peschel
5. Hermínia de Lencastre
6. Sahreena S. Lakhundi

Citations in the corpus

• Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology (2018, background): “As HA-MRSA accounts for a high proportion of infection in hospitalized patients, in order to control the infection rate, it is important to understand the associated risk factors (448).”
• Methicillin-resistant Staphylococcus aureus (2018, methodology): “A subsequent costeffectiveness analysis using these data showed that the mean cost saved per treated carrier was €1,911 (REF.155).”
• The Bicomponent Pore-Forming Leucocidins of Staphylococcus aureus (2014, background): “(5) Activation of apoptosis via mitochondrial disruption potentially caused by pore formation.”